Effects on thrombin generation of the platelet glycoprotein IIb/IIIa inhibitors abciximab versus tirofiban during coronary intervention

Am J Cardiol. 2001 May 15;87(10):1231-3: A8. doi: 10.1016/s0002-9149(01)01506-5.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Abciximab
  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal / therapeutic use*
  • Anticoagulants / administration & dosage
  • Atherectomy, Coronary
  • Coronary Disease / blood
  • Coronary Disease / therapy*
  • Female
  • Heparin / administration & dosage
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Male
  • Middle Aged
  • Peptide Fragments / blood
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Prothrombin
  • Stents
  • Thrombin / metabolism*
  • Tirofiban
  • Tyrosine / analogs & derivatives*
  • Tyrosine / therapeutic use*
  • Whole Blood Coagulation Time

Substances

  • Antibodies, Monoclonal
  • Anticoagulants
  • Immunoglobulin Fab Fragments
  • Peptide Fragments
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • prothrombin fragment 1.2
  • Tyrosine
  • Prothrombin
  • Heparin
  • Thrombin
  • Tirofiban
  • Abciximab